AI assistant
Sending…
NEKTAR THERAPEUTICS — Director's Dealing 2010
Feb 3, 2010
32134_dirs_2010-02-03_288fd010-fc0b-4907-ba1e-c3c868007d95.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2010-02-01
Reporting Person: ROBIN HOWARD W (Director, President & CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-02-01 | Stock Option | $11.34 | A | 500000 | Acquired | 2018-02-01 | Common Stock (500000) | Direct |
Footnotes
F1: The shares subject to this stock option shall vest on a monthly pro-rata basis over a period of four (4) years from the grant date (February 1, 2010).
More from NEKTAR THERAPEUTICS
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Capital/Financing Update
2026
May 8
Annual Report
2026
Apr 24
Capital/Financing Update
2026
Apr 23
Capital/Financing Update
2026
Apr 23
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 20
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 20